Published in Arzneimittelforschung on January 01, 1983
Qinghaosu (artemisinin): an antimalarial drug from China. Science (1985) 4.95
2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents. J Med Chem (1979) 2.86
Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am J Trop Med Hyg (1994) 2.73
Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med (1993) 2.61
Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science (1987) 2.11
Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis (1994) 2.02
Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials. J Med Entomol (1990) 2.02
Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis. N Engl J Med (1982) 1.68
Look-back investigation after human immunodeficiency virus seroconversion in a pediatric dentist. J Infect Dis (1994) 1.46
Prompt confirmation of Rocky Mountain spotted fever: identification of rickettsiae in skin tissues. J Infect Dis (1976) 1.46
The threat of infectious diseases in Somalia. N Engl J Med (1993) 1.38
Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Trans R Soc Trop Med Hyg (1985) 1.31
2-Acetylpyridine thiosemicarbazones. 4. Complexes with transition metals as antimalarial and antileukemic agents. J Med Chem (1982) 1.28
Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J Immunol (1989) 1.24
Inhibition of clinically significant bacterial organisms in vitro by 2-acetylpyridine thiosemicarbazones. Antimicrob Agents Chemother (1980) 1.23
Activation of macrophages to kill rickettsiae and Leishmania: dissociation of intracellular microbicidal activities and extracellular destruction of neoplastic and helminth targets. Contemp Top Immunobiol (1984) 1.20
ELISA method for detecting Plasmodium falciparum circumsporozoite antibody. Bull World Health Organ (1989) 1.20
Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design. J Infect Dis (1995) 1.19
Isolation of artemisinin (qinghaosu) from Artemisia annua growing in the United States. J Nat Prod (1984) 1.17
Antimalarial activity of new water-soluble dihydroartemisinin derivatives. J Med Chem (1987) 1.17
2-Acetylpyridine thiosemicarbazones. 2. N4,N4-Disubstituted derivatives as potential antimalarial agents. J Med Chem (1979) 1.16
Dose- and time-dependent relations between infective Anopheles inoculation and outcomes of Plasmodium falciparum parasitemia among children in western Kenya. Am J Epidemiol (1997) 1.14
The threat of infectious disease in Americans returning from Operation Desert Storm. N Engl J Med (1991) 1.14
Isolation of HIV-1 from the blood of seropositive adults: patient stage of illness and sample inoculum size are major determinants of a positive culture. The Walter Reed Retroviral Research Group. J Acquir Immune Defic Syndr (1990) 1.11
Predicting outcome in malaria: correlation between rate of exposure to infected mosquitoes and level of Plasmodium falciparum parasitemia. Am J Trop Med Hyg (1994) 1.10
Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. Am J Trop Med Hyg (1982) 1.09
Clinical and epidemiological correlates of Pseudomonas typing. J Infect Dis (1974) 1.09
Protoberberine alkaloids as antimalarials. J Med Chem (1988) 1.08
Malaria in asplenic mice: effects of splenectomy, congenital asplenia, and splenic reconstitution on the course of infection. Am J Trop Med Hyg (1980) 1.08
Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy. N Engl J Med (1989) 1.08
Berberine derivatives as antileishmanial drugs. Antimicrob Agents Chemother (1990) 1.06
Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission. N Engl J Med (1977) 1.04
Campylobacter pylori, NSAIDS, and smoking: risk factors for peptic ulcer disease. Am J Gastroenterol (1989) 1.04
Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis (1998) 1.00
2-Acetylpyridine thiosemicarbazones. 9. Derivatives of 2-acetylpyridine 1-oxide as potential antimalarial agents. J Med Chem (1984) 1.00
Cutaneous leishmaniasis following local trauma: a clinical pearl. Clin Infect Dis (2000) 0.99
Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84). J Infect Dis (1979) 0.98
Antiviral activity of 2-acetylpyridine thiosemicarbazones against herpes simplex virus. Antimicrob Agents Chemother (1981) 0.97
Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline, and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model. Antiviral Res (1986) 0.96
Plasmodium falciparum gametocytemia in Kenyan children: associations among age, intensity of exposure to transmission, and prevalence and density of subsequent gametocytemia. Am J Trop Med Hyg (1997) 0.94
In vitro assessment of 2-acetylpyridine thiosemicarbazones against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother (1982) 0.93
Initial clinical evaluation of a new Rocky Mountain spotted fever vaccine of tissue culture origin. J Infect Dis (1978) 0.91
Isolation of Leishmania donovani from Phlebotomus martini in Baringo district, Kenya. Trans R Soc Trop Med Hyg (1988) 0.91
Evaluation of promastigote and amastigote antigens in the indirect fluorescent antibody test for American cutaneous leishmaniasis. Am J Trop Med Hyg (1983) 0.91
Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.90
Macrophage activation to kill Leishmania tropica: kinetics of macrophage response to lymphokines that induce antimicrobial activities against amastigotes. J Immunol (1984) 0.90
The inhibitory effect of sodium alginate on antibiotic activity against mucoid and non-mucoid strains of Pseudomonas aeruginosa. J Antimicrob Chemother (1987) 0.90
Post kala-azar dermal leishmaniasis: the Kenyan experience. East Afr Med J (1991) 0.90
2-Acetylpyridine thiosemicarbazones. 5. 1-[1-(2-Pyridyl)ethyl]-3-thiosemicarbazides as potential antimalarial agents. J Med Chem (1983) 0.90
Prophylactic treatment of Rocky Mountain spotted fever. J Clin Microbiol (1978) 0.90
Identification of Rickettsia conorii infection by polymerase chain reaction in a soldier returning from Somalia. Clin Infect Dis (1994) 0.89
Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis. Clin Infect Dis (1998) 0.89
Correlations between structure and antimycobacterial activity in a series of 2-acetylpyridine thiosemicarbazones. J Gen Microbiol (1982) 0.89
Post-kala-azar dermal leishmaniasis occurring long after cure of visceral leishmaniasis in Kenya. East Afr Med J (1986) 0.88
Synthesis and biological evaluation of 4-chloro-3, 5-dinitrobenzotrifluoride analogues as antileishmanial agents. J Med Chem (1998) 0.88
Filariasis testing in a jird model: new drug leads from some old standbys. Am J Trop Med Hyg (1994) 0.88
Concurrent infection with Leishmania donovani and Leishmania major in a Kenyan patient: clinical description and parasite characterization. Am J Trop Med Hyg (1991) 0.87
Suppression of cellular immune responses in guinea pigs infected with spotted fever group rickettsiae. Infect Immun (1978) 0.87
Leishmania donovani parasites in the nasal secretions, tonsillopharyngeal mucosa, and urine centrifugates of visceral leishmaniasis patients in Kenya. Am J Trop Med Hyg (1993) 0.87
Bacterial flora of one hundred and twelve combat wounds. Mil Med (1968) 0.87
Antibiotic topical spray applied in a simulated combat wound. Arch Surg (1967) 0.86
Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 2. Stereospecificity of the ether side chain. J Med Chem (1989) 0.86
In vitro antimalarial activity of Brucea javanica against multi-drug resistant Plasmodium falciparum. Planta Med (1986) 0.84
Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries. Am J Trop Med Hyg (1985) 0.84
Artemisinin: an endoperoxidic antimalarial from Artemisia annua L. Fortschr Chem Org Naturst (1997) 0.84
Plasmodium berghei: the antimalarial action of artemisinin and sodium artelinate in vivo and in vitro, studied by flow cytometry. Exp Parasitol (1990) 0.84
Conversion of artemisinin (qinghaosu) to iso-artemisitene and to 9-epi-artemisinin1. Planta Med (1987) 0.83
Clinical performance of a polymerase chain reaction testing algorithm for diagnosis of HIV-1 infection in peripheral blood mononuclear cells. J Med Virol (1991) 0.83
Activation of the kallikrein-kinin system in Rocky Mountain spotted fever. Ann Intern Med (1978) 0.83
Clinical features of inflammatory dermatoses in human immunodeficiency virus type 1 disease and their correlation with Walter Reed stage. Military Medical Consortium for Applied Retroviral Research. J Am Acad Dermatol (1993) 0.83
Generalized chronic dermatophytosis in patients with human immunodeficiency virus type I infection and CD4 depletion. Arch Dermatol (1991) 0.82
Reductive electrochemical HPLC assay for artemisinin (qinghaosu). Planta Med (1985) 0.82
Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo. Am J Trop Med Hyg (1993) 0.82
Molecular characterization of Plasmodium falciparum S-adenosylmethionine synthetase. Biochem J (1999) 0.82
Role of topical antibiotic spray in simulated mass casualty wounds. Surg Forum (1967) 0.81
Topical spray of antibiotics in simulated combat wounds. IV. Dose factor. Arch Surg (1968) 0.81
A retrospective analysis of diseases associated with indeterminate HIV western blot patterns. Mil Med (1991) 0.81
2-Acetylpyridine thiosemicarbazones. 12. Derivatives of 3-acetylisoquinoline as potential antimalarial agents. Arzneimittelforschung (1986) 0.81
Hematogenous group B streptococcal osteomyelitis in an adult. South Med J (1984) 0.80
Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 3. Aromatic amine analogues. J Med Chem (1990) 0.80
Antimalarial activity of new dihydroartemisinin derivatives. 5. Sugar analogues. J Med Chem (1992) 0.80
Evaluation of the in vitro antimalarial activity of Picralima nitida extracts. J Ethnopharmacol (1992) 0.80
Short report: floxacrine analog WR 243251 inhibits hematin polymerization. Am J Trop Med Hyg (2001) 0.80
Artemisitene, a New Sesquiterpene Lactone Endoperoxide from Artemisia annua. Planta Med (1985) 0.80
Effect of human circumsporozoite antibodies in Plasmodium-infected Anopheles (Diptera: Culicidae). J Med Entomol (1989) 0.80
2-Acetylpyridine thiosemicarbazones. 6.2-Acetylpyridine and 2-butyrylpyridine thiosemicarbazones as antileukemic agents. Arzneimittelforschung (1983) 0.80
Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis. Clin Infect Dis (1998) 0.80
Production of artemisinin in tissue cultures of Artemisia annua. J Nat Prod (1986) 0.79